Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia

Blood

Volumn 124, Issue 4, 2014, Pages 655-657

  Serwas, Nina Kathrin ^a   Cagdas, Deniz ^b   Ban, Sol A ^a   Bienemann, Kirsten ^c   Salzer, Elisabeth ^a   Tezcan, Ilhan ^b   Borkhardt, Arndt ^c   Sanal, Ozden ^b   Boztug, Kaan ^a,d  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b HACETTEPE UNIVERSITY   (Turkey)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 INDUCIBLE T CELL KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY RESPONSE; BRONCHIECTASIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS; EXON; FOLLOW UP; GENETIC ASSOCIATION; HEPATOMEGALY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INDUCIBLE T CELL KINASE DEFICIENCY; LEIOMYOMA; LETTER; LUNG INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; NATURAL KILLER CELL; NONSENSE MEDIATED MRNA DECAY; NONSENSE MUTATION; PRIORITY JOURNAL; SPLENOMEGALY; TURK (PEOPLE); VIRUS LOAD;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; MALE; MUTATION; PROGNOSIS; PROTEIN-TYROSINE KINASES; T-LYMPHOCYTOPENIA, IDIOPATHIC CD4-POSITIVE;

EID: 84904872011     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-564930     Document Type: Letter

References (11)

1. de Préval C, Lisowska-Grospierre B, Loche M, Griscelli C, Mach B. A transacting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature. 1985;318(6043):291-293. (Pubitemid 16206732)
2. Kuijpers TW, Ijspeert H, van Leeuwen EM, et al. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117(22):5892-5896.
3. Nehme NT, Pachlopnik Schmid J, Debeurme F, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood. 2012;119(15):3458-3468.
4. Hauck F, Randriamampita C, Martin E, et al. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin Immunol. 2012;130(5):1144-1152, e1111.
5. Salzer E, Kansu A, Sic H, et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J Allergy Clin Immunol. 2014;133(6):1651, e12.
6. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol. 2005;23:549-600. (Pubitemid 40563180)
7. Liao XC, Littman DR. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity. 1995;3(6):757-769. (Pubitemid 26091149)
8. Stepensky P, Weintraub M, Yanir A, et al. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica. 2011;96(3):472-476.
9. Mansouri D, Mahdaviani SA, Khalilzadeh S, et al. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int Arch Allergy Immunol. 2012;158(4): 418-422.
10. Huck K, Feyen O, Niehues T, et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009;119(5):1350-1358.
11. Linka RM, Risse SL, Bienemann K, et al. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia. 2012;26(5):963-971.